BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11992862)

  • 1. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
    Korah S; Kuriakose T
    Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine retinopathy.
    Maturi RK; Folk JC; Nichols B; Oetting TT; Kardon RH
    Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract]   [Full Text] [Related]  

  • 9. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a follow-up protocol for patients on chloroquine and hydroxychloroquine treatment.
    Sanabria MR; Toledo-Lucho SC
    Arch Soc Esp Oftalmol; 2016 Jan; 91(1):10-4. PubMed ID: 26627497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF; Chien FY; Johnson MW
    JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB; Marmor MF
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA; Maker MP; Marmor MF
    JAMA Ophthalmol; 2019 Jan; 137(1):109-110. PubMed ID: 30452517
    [No Abstract]   [Full Text] [Related]  

  • 19. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.